FAJJ Med
The computed 12-month bankruptcy probability of FAJJ Med is 3.2% (moderate). The 2024 annual accounts show equity of €99k and a net result of €94k. The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €99k |
| Net result | €94k |
| Active | 2 yrs |
| Locations | 1 |
Mixed profile: strong on profitability, weaker on solvency.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €183k |
| Net profit | €94k |
| Cash flow | €143k |
| Staff costs | - |
| Income taxes | €33k |
| Dividends | - |
| Total assets | €482k |
| Equity | €99k |
| Debt | €383k |
| of which ≤ 1y | €383k |
| of which > 1y | - |
| Working capital | €-345k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.10 |
| Quick ratio | 0.10 |
| Working capital ratio | -71.6% |
| Solvency | 20.5% |
| Debt / equity | 3.88 |
| Long-term debt ratio | - |
| Interest coverage | 26.09 |
| Gross margin | - |
| Net margin | - |
| ROA | 19.5% |
| ROE | 94.9% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (22 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €482k |
| Fixed assets | 21/28 | €444k |
| Intangible fixed assets | 21 | €441k |
| Tangible fixed assets | 22/27 | €3k |
| Current assets | 29/58 | €38k |
| Amounts receivable within one year | 40/41 | €22k |
| Cash & bank | 54/58 | €13k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €482k |
| Equity | 10/15 | €99k |
| Contributions / capital | 10/11 | €5k |
| Accumulated profits (losses) | 14 | €94k |
| Amounts payable | 17/49 | €383k |
| Amounts payable within one year | 42/48 | €383k |
| Trade debts payable within one year | 44 | €866 |
| Income statement | ||
| Gross operating margin | 9900 | €183k |
| Operating result | 9901 | €134k |
| Financial income | 75 | €113 |
| Financial charges | 65 | €7k |
| Result before taxes | 9903 | €127k |
| Income taxes | 67/77 | €33k |
| Net result for the period | 9904 | €94k |
| Result to be appropriated | 9905 | €94k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 04-01-2024 |
| Status | Active |
| Postal code | 4140 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62045A0051/00C002 | Wallonia | 5,154 m² | 1 · 139 m² | 8.6 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
| Legal nameFR | FAJJ Med |